ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

154
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
bullishKakaopay
21 Oct 2021 18:27

Kakao Pay Book Building Results

Maeil Business Daily reported after the market close today that Kakao Pay has successfully completed its IPO book building with the IPO price of...

Logo
434 Views
Share
bullishSK Inc
04 Oct 2021 20:09

SK Inc - SoTP Valuation Analysis and 3 Key Catalysts (SK E&S, SK Pharmteco, & SK Siltron)

In this insight, we provide an updated NAV valuation analysis of SK Inc. Our updated base case valuation of SK Inc is 381,838 won per share,...

Logo
424 Views
Share
bullishKrafton
31 Aug 2021 17:21

KRX BBIG Index Rebalance: Krafton, SK Bioscience, SK IE Tech Included (Among Others)

Krafton has been added to the Game index, SK IE Tech added to the Battery index, SK Bioscience to the Bio index. Lots of flow on some names....

Logo
330 Views
Share
bullishKakaoBank
07 Aug 2021 17:53

Kakao Bank - MSCI Done, Missed FTSE by a Whisker.

Kakao Bank (KB), South Korea’s largest digital bank, raised US$2.2bn in its South Korean IPO. It ended the first day of trading up 79% from its IPO...

Logo
487 Views
Share
bullishKrafton
12 Jul 2021 08:01

A Guide to Notable Korean Sector Indices

Among the hundreds of local sector-themed indices, indices with significant AUM and passive impact are summarized in this post.

Logo
379 Views
Share
x